TruSkin®: Study for the Treatment of Chronic Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study Comparing the Clinical Outcomes of TruSkin® and an Active Comparator for the Treatment of Chronic Diabetic Foot Ulcers
Sponsor: Osiris Therapeutics
Terminated
Osiris decision
Other terminated trials from Osiris Therapeutics
- Chronic Diabetic Foot Ulcers · Phase PHASE3 · Jun 2017
- Chronic Venous Leg Ulcers · Phase PHASE4 · Apr 2017
More terminations from Osiris Therapeutics
Other Diabetic Foot Ulcers trials with similar outcome
This PHASE4 trial investigates Diabetic Foot Ulcers and is currently terminated or withdrawn. Osiris Therapeutics leads this study, which shows 7 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE4
▶ Show 2 earlier versions
-
May 2017 — Jun 2018 [monthly]
Terminated PHASE4
Status: Recruiting → Terminated
-
Jan 2017 — May 2017 [monthly]
Recruiting PHASE4
First recorded
Jul 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Osiris Therapeutics
For direct contact, visit the study record on ClinicalTrials.gov .